Equity Details
Price & Market Data
Price: $68.53
Daily Change: -$0.70 / 1.02%
Daily Range: $67.87 - $71.39
Market Cap: $2,617,783,552
Daily Volume: 597,207
Performance Metrics
1 Week: 1.39%
1 Month: 0.10%
3 Months: -8.32%
6 Months: -18.27%
1 Year: 47.03%
YTD: -13.70%
About Disc Medicine, Inc. (IRON)
Discover the financial pulse of Disc Medicine, Inc. (IRON). Current price: 68.53, daily change: -$0.70 / 1.02%. Market cap: 2,617,783,552. Get YTD and 52-week performance.
Company Details
Employees: 155
Sector: Health technology
Industry: Biotechnology
Country: United States
Details
Disc Medicine, Inc., together with its subsidiaries, a clinical-stage biopharmaceutical company, engages in the discovery, development, and commercialization of novel treatments for patients suffering from serious hematologic diseases in the United States. The company has assembled a portfolio of clinical and preclinical product candidates that aim to modify fundamental biological pathways associated with the formation and function of red blood cells, primarily heme biosynthesis and iron homeostasis. Its pipeline includes bitopertin for the treatment of erythropoietic porphyrias, including erythropoietic protoporphyria, X-linked protoporphyria, and diamond-blackfan anemia; DISC-0974 for the treatment of anemia of myelofibrosis, and anemia of chronic kidney disease; and DISC-3405 for the treatment of polycythemia vera, and other hematologic disorders. It also develops preclinical programs include DISC-0998, for the treatment of anemia associated with inflammatory diseases. The company was founded in 2017 and is headquartered in Watertown, Massachusetts.